Pharmacy Error Injury Lawyer Blog
Last updated August 21, 2026 · Reviewed by Jack D. Lebowitz
Two compounded glutathione products were pulled from the market in August 2026, both over elevated bacterial endotoxin levels in multi-dose vials. One pharmacy recalled three lots on August 5, and a second recalled a lot on August 19, both announced through the FDA. Neither was a labeling mistake or the wrong drug in the wrong bottle. The recalled product was the drug it claimed to be, and it was unsafe anyway.
That distinction carries real legal weight. A contamination case does not depend on proving that a pharmacist grabbed the wrong shelf; it depends on proving that a sterile product left the facility in a condition it should never have been in. Patients who received an injection and then had a reaction often never learn a recall was issued at all, because the notice goes to the clinic or the distributor rather than to them.
Injuries traced to a compounded product rather than to a dispensing mistake still fall within pharmacy misfill and medication error claims, which Lebowitz & Mzhen Personal Injury Lawyers brings for patients across Maryland.
What an Outsourcing Facility Is Allowed to Compound
An outsourcing facility is a compounding operation registered with the FDA to produce sterile drugs in volume, without needing a prescription for a specific named patient.
The framework governing them is 21 U.S.C. § 353b, and its conditions are concrete. Compounding has to happen under the supervision of a licensed pharmacist. The facility registers annually and reports what it produces twice a year. Bulk substances have to meet defined standards. Every drug has to be labeled with the words “This is a compounded drug.” Notably, an outsourcing facility is not required to be a licensed pharmacy, which surprises most patients who assume anything injected in a clinic came from one.
Why an Endotoxin Recall Is Different From a Misfill
Bacterial endotoxins are fragments of bacterial cell walls that survive ordinary sterilization and cause a reaction when injected. Both August recalls carried the same risk statement, describing a reasonable probability of fever, hypotension, inflammatory reactions, anaphylactic shock, and death, and both pharmacies reported adverse events that had already occurred. The reaction can begin within hours of the injection.
Neither recall listed Maryland among the states its lots reached, which is worth saying plainly. The reason a Maryland patient should still care is that compounded sterile products move through clinics, infusion centers, and med spas the same way in every state, and the questions worth asking are identical wherever the vial came from.
For a patient, the difficulty is connecting the two events. A misfill announces itself, since the pill looks wrong or the label names a drug nobody prescribed. Contamination does not. Someone who felt violently ill the evening after an infusion and recovered over a few days has no particular reason to suspect the vial, and by the time a recall notice reaches the provider, the lot number on that patient’s chart may be the only surviving link. Those lot numbers, the administration records, and the clinic’s purchasing records are the evidence that makes the claim provable, and a products liability claim built on them looks quite different from a negligence claim against a dispensing pharmacist.
What a Maryland Patient Can Do After a Recall Notice
Timing rules vary with who the defendant turns out to be. Most Maryland personal injury claims run three years from the date the action accrues under Md. Code, Cts. & Jud. Proc. § 5-101, while claims against a health care provider run on the different schedule in § 5-109. Which one applies to a compounder is a question worth answering early rather than after a deadline has passed.
If you received a compounded injection and had a significant reaction afterward, you can ask the provider who administered it for the product’s name, its manufacturer, and its lot number, and whether that lot was subject to a recall. Providers keep this information as a matter of routine, and the request is an ordinary one.
Medication cases reward patience with records more than almost any other kind of injury claim. We work backward from the chart to the lot, from the lot to the facility that produced it, and from the facility to its inspection and recall history, because that chain is what turns a bad reaction into a provable claim. Our attorneys have handled medication injury matters for Maryland patients for many years, and the questions worth asking are ones most people would have no reason to know to ask.
Trace a Medication Injury Back to Its Source
A serious reaction to an injected medication is worth investigating even when nothing about it looked like an error at the time. Patients harmed by medication errors in Maryland and Washington, D.C. are represented by Lebowitz & Mzhen Personal Injury Lawyers. To have someone request the records that identify the product and its lot, call (800) 654-1949 or contact the firm for a free case evaluation. These matters run on contingency, and no fee is owed unless the firm recovers.